Log In
Print
BCIQ
Print
Print this Print this
 

Dengue fever vaccine

  Manage Alerts
Collapse Summary General Information
Company Themis Bioscience GmbH
DescriptionVaccine developed using Thermaxyn technology that uses a single measles virus vector expressing the EDIII sequences of all 4 strains of dengue virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsPrevent dengue fever
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today